Related Experiment Video
Updated: Feb 8, 2026

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
The effect of combined therapy for treatment of monotherapy-resistant PDA in preterm infants
Sadık Yurttutan1, Aydın Bozkaya1, Füheda Hüdayioglu2
1a Department of Pediatrics, Faculty of Medicine , Kahramanmaras Sutcu Imam University , Kahramanmaraş , Turkey.
Insights
Combined therapy with paracetamol and ibuprofen effectively treated hemodynamically significant PDA (hsPDA) in preterm infants resistant to single-drug treatment. This approach offers a viable alternative before considering surgical PDA ligation.
Area of Science:
- Neonatalogy
- Pediatric Cardiology
Background:
- Hemodynamically significant PDA (hsPDA) is a common complication in preterm infants.
- Monotherapy for hsPDA can be ineffective in some cases, necessitating alternative treatments.
Purpose of the Study:
- To evaluate the efficacy of combined paracetamol and ibuprofen therapy for hsPDA in preterm infants.
- To assess this combined treatment in infants with hsPDA resistant to monotherapy.
Main Methods:
- Infants with persistent hsPDA unresponsive to monotherapy received combined paracetamol and ibuprofen.
- Paracetamol was administered at 15 mg/kg every 6 hours for 5 days, with ibuprofen given at 10 mg/kg followed by 5 mg/kg at 24 and 48 hours.
- Echocardiography assessed hsPDA after treatment; surgical ligation was considered for persistent cases.
Main Results:
- Combined therapy successfully treated 75% (9 out of 12) of infants with monotherapy-resistant hsPDA.
- Three infants did not respond to the combined treatment and subsequently underwent surgical PDA ligation.
Conclusions:
- Combined paracetamol and ibuprofen therapy presents a promising option for treating monotherapy-resistant hsPDA in preterm infants.
- This combined pharmacological approach should be considered prior to surgical intervention for hsPDA.
Abstract:
Objective: Hemodynamically significant PDA (hsPDA) is one of the most common problems in preterm infants. This study was conducted to investigate the effect of combined pharmacological (paracetamol + ibuprofen) therapy on monotherapy-resistant hsPDA in infants. Subject and methods: The study included infants with persistent hsPDA, unresponsive to monotherapy. Combined treatment (paracetamol + ibuprofen) was started as paracetamol at a dose of 15 mg/kg every 6 hours for 5 days, and ibuprofen at an initial dose of 10 mg/kg followed by 5 mg/kg at 24 and 48 hours. Echocardiographic evaluation was performed at 2 days after the end of treatment. If hsPDA persisted after the combined treatment, a surgical PDA ligation was considered. Results: A total of 12 infants were enrolled and 9 infants (75%) with monotherapy-resistant PDA were successfully treated with combined therapy. In three patients, no response was obtained to the combined treatment so surgical ligation was applied. Conclusions: Combined therapy may be a useful treatment option for monotherapy-resistant hsPDA in preterm infants. Before surgical ligations, this combined therapy option should be considered.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Gene Therapy
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Resistivity
Resistance

